Location
Booth: XXX
What’s next for preclinical toxicology and safety screening? Find out by meeting us at the Northern California Society of Toxicology (NorCal SOT) 2025 Fall Symposium.
Whether you’re working in industry, academia, or regulatory science, our scalable iPSC-based platforms deliver the predictive power and reproducibility needed to support confident decision-making in toxicology studies.
Let’s connect to discuss how we can help you accelerate timelines, reduce animal testing, and generate data that translate.
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.